GS0051: Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives
GS0421: Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals
Case File Event Statements
4/25/2006 - 18 years ago
13 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDType:MAB2
4/25/2006 - 18 years ago
12 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
9/27/2005 - 19 years ago
11 - INQUIRY AS TO SUSPENSION MAILEDType:CNSI
9/27/2005 - 19 years ago
10 - SUSPENSION INQUIRY WRITTENType:CNSI
9/24/2005 - 19 years ago
9 - LIE CHECKED SUSP - TO ATTY FOR ACTIONType:RCCK
3/14/2005 - 19 years ago
8 - LETTER OF SUSPENSION MAILEDType:CNSL
3/13/2005 - 19 years ago
7 - SUSPENSION LETTER WRITTENType:CNSL
3/11/2005 - 19 years ago
6 - AMENDMENT FROM APPLICANT ENTEREDType:ACEC
2/25/2005 - 19 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA